Synthesis and anti-cancer activities of apigenin derivatives

Medicinal Chemistry

Volumn 10, Issue 7, 2014, Pages 747-752

  Zheng, Xing ^a,b   Yu, Liuying ^a   Yang, Jing ^b   Yao, Xu ^a   Yan, Wenna ^a   Bo, Shaowei ^a   Liu, Ya ^a   Wei, Yun ^a   Wu, Zhiyi ^a   Wang, Guan ^a  

^a UNIVERSITY OF SOUTH CHINA   (China)

^b Bureau of Commodity Quality Supervision and Inspection   (China)

Author keywords

Anti cancer activities; Apigenin; Baker venkataraman reaction; Flavonoids; MTT method; SAR

Indexed keywords

2 [4 (DIETHYLHEXYL)PHENYL] 5,7 (DIETHYLHEXYL)OXY 4H CHROMEN 4 ONE; 2 [4 (DIFLUORMETHOXY)PHENYL] 5,7 DIETHOXY 3 ETHYL 4H CHROMEN 4 ONE; 2 [4 (DIFLUOROMETHOXY)PHENYL] 5,7 (DIETHYLHEXYL)OXY 4H CHROMEN 4 ONE; 2 [4 (DIFLUOROMETHOXY)PHENYL] 5,7 DIETHOXY 3 ETHYL 4H CHROMEN 4 ONE; 2 [4 (DIFLUOROMETHOXY)PHENYL] 5,7 DIETHOXY 4H CHROMEN 4 ONE; 2 [4 (DIFLUOROMETHOXY)PHENYL] 5,7 DIMETHOXY 3 ETHYL 4H CHROMEN 4 ONE; 2 [4 (DIFLUOROMETHOXY)PHENYL] 5,7 DIMETHOXY 4H CHROMEN 4 ONE,; 7 BENZYL 2 [3 (TRIFLUOROMETHYL)PHENYL] 4H CHROMEN 4 ONE; 7 ETHOXY 2 [3 (TRIFLUOROMETHYL)PHENYL] 4H CHROMEN 4 ONE; 7 METHOXY 2 [3 (TRIFLUOROMETHYL)PHENYL] 4H CHROMEN 4 ONE; ANTINEOPLASTIC AGENT; APIGENIN; APIGENIN DERIVATIVE; FLUOROURACIL; PHLOROGLUCINOL; RESORCINOL; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CLINICAL EVALUATION; CONTROLLED STUDY; CYTOTOXICITY; DRUG STRUCTURE; DRUG SYNTHESIS; HL 60 CELL LINE; HT 29 CELL LINE; HUMAN; HUMAN CELL; IC50; IN VITRO STUDY; MTT ASSAY; PRIORITY JOURNAL; STRUCTURE ACTIVITY RELATION; CELL DEATH; CELL PROLIFERATION; CHEMICAL STRUCTURE; CHEMISTRY; DOSE RESPONSE; DRUG EFFECTS; DRUG SCREENING; MOLECULAR WEIGHT; SYNTHESIS; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS; APIGENIN; CELL DEATH; CELL LINE, TUMOR; CELL PROLIFERATION; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SCREENING ASSAYS, ANTITUMOR; HL-60 CELLS; HT29 CELLS; HUMANS; MOLECULAR STRUCTURE; MOLECULAR WEIGHT; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 84925661172     PISSN: 15734064     EISSN: 18756638     Source Type: Journal    
DOI: 10.2174/1573406410666140307152557     Document Type: Article

References (27)

1. Center, M. M.; Jemal, A.; Smith, R. A.; Ward, E. Worldwide variations in colorectal cancer. CA Cancer J. Clin., 2009, 59, 366-78.
2. Curado, M. P.; Pontes, T.; Guerra-Yi, M.; Cancela, M. C. Leukemia mortality trends among children, adolescents, and young adults in Latin America. Rev. Panam. Salud. Publica, 2011, 29, 96-102.
3. Steward, W. P.; Brown, K. Cancer chemoprevention: a rapidly evolving field. Br. J. Cancer. 2013, 109, 1-7.
4. Miean, K. H.; Mohamed, S. Flavonoid, (Myricetin, Quercetin, Kaempferol, Luteolin, and Apigenin) content of edible tropical plants. J. Agric. Food. Chem., 2001, 49, 3106-12.
5. Soares, R.; Azevedo, I. Apigenin: is it a pro- or anti-inflammatory agent? Am. J. Pathol, 2006, 168, 1762-1763.
6. Romanová, D.; Vachálková, A.; Cipák, L.; Ovesná, Z; Rauko, P. Study of antioxidant effect of apigenin, luteolin and quercetin by DNA protective method. Neoplasma, 2001, 48, 104-7.
7. Czyz, J.; Madeja, Z.; Irmer, U.; Korohoda, W.; Hülser, D. F. Flavonoid apigenin inhibits motility and invasiveness of carcinoma cells in vitro. Int. J. Cancer, 2005, 114, 12-18.
8. Kumar, S.; Madaan, R.; Sharma, A. Estimation of apigenin, an anxiolytic constituent, in Turnera aphrodisiaca. Indian. J. Pharm. Sci., 2008, 70, 847-851.
9. Zhu, Y.; Mao, Y. Q.; Chen, H.; Lin, Y. W.; Hu, Z. H.; Wu, J.; Xu, X.; Xu, X. L.; Qin, J.; Xie, L. P. Apigenin promotes apoptosis, inhibits invasion and induces cell cycle arrest of T24 human bladder cancer cells. Cancer Cell Int., 2013, 13, 54-60.
10. Cao, X.; Liu, B.; Cao, W.; Zhang, W.; Zhang, F.; Zhao, H.; Meng, R.; Zhang, L.; Niu, R.; Hao, X.; Zhang, B. Autophagy inhibition enhances apigenin-induced apoptosis in human breast cancer cells. Chin. J. Cancer Res., 2013, 25, 212-22.
11. Wang, Q. R.; Yao, X. Q.; Wen, G.; Fan, Q.; Li, Y. J.; Fu, X. Q.; Li, C. K.; Sun, X. G. Apigenin suppresses the growth of colorectal cancer xenografts via phosphorylation and up-regulated FADD expression. Oncol. Lett., 2011, 2, 43-47.
12. Budhraja, A.; Gao, N.; Zhang, Z.; Son, Y. O.; Cheng, S.; Wang, X.; Ding, S.; Hitron, A.; Chen, G.; Luo, J.; Shi, X. Apigenin induces apoptosis in human leukemia cells and exhibits anti-leukemic activity in vivo. Mol. Cancer Ther., 2012, 11, 132-42.
13. Meyer, H.; Bolarinwa, A.; Wolfram, G.; Linseisen, J. Bioavailability of apigenin from Apiin-Rich Parsley in humans. Ann. Nutr. Metab., 2006, 50, 167-72.
14. Rithidech, K. N.; Tungijai, M.; Whorton, E. B. Protective effects of apigenin on radiation-induced chromosomal damage in human lymphocytes. Muta. Res., 2005, 585, 96-104.
15. Siddique, Y. H.; Afzal, M. Antigenotoxic effect of apigenin against mitomycin C induced genotoxic damage in mice bone marrow cells. Food. Chem. Toxicol, 2009, 47, 536-539.
16. Bektic, J.; Guggenberger, R.; Spengler, B.; Christoffel, V.; Pelzer, A.; Berger, AP.; Ramoner, R.; Bartsch, G.; Klocker, H. The flavonoid apigenin inhibits the proliferation of prostatic stromal cells via the MAPK-pathway and cell-cycle arrest in G1/S. Maturitas, 2006, 55, S37-S46.
17. Plochmann, K.; Korte, G.; Koutsilieri, E.; Koutsilieri, E.; Richling, E.; Riederer, P.; Rethwilm, A.; Schreier, P.; Scheller, C. Structureactivity relationships of flavonoid-induced cytotoxicity on human leukemia cells. Arch. Biochem. Biophys, 2007, 460, 1-9.
18. Cárdenas, M.; Marder, M.; Blank, V. C.; Roguin, L. P. Antitumor activity of some natural flavonoids and synthetic derivatives on various human and murine cancer cell lines. Bioorg. Med. Chem., 2006, 14, 2966-71.
19. Singh, R. P.; Shreeve, J. M. Nucleophilic trifluoromethylation reactions of organic compounds with (trifluoromethyl) trimethylsilane. Tetrahedron, 2000, 56, 7613-32.
20. Zheng, X.; Zhao, F. F.; Liu, Y. M.; Yao, X.; Zheng, Z. T.; Luo, X.; Liao, D. F. Synthesis and preliminary biological evaluation of chrysin derivatives as potential anticancer drugs. Med. Chem., 2010, 6, 6-8.
21. Zheng, X.; Cao, J. G.; Meng, W. D.; Qing, F. L. Synthesis and anticancer effect of B-Ring trifluoromethylated. Bioorg. Med. Chem. Lett., 2003, 13, 3423-27.
22. Mosman, T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods, 1983, 65, 55-63.
23. Chang, L. S.; Li, C. B.; Qin, N.; Jin, M. N.; Duan, H. Q. Synthesis and antidiabetic activity of 5, 7-dihydroxyflavonoids and analogs. Chem. Biodivers., 2012, 9, 162-9.
24. Wang, C. L.; Li, H. Q.; Meng, W. D.; Qing, F. L. Trifluoromethylation of flavonoids and anti-tumorractivity of the trifluoromethylated flavonoid derivatives. Bioorg. Med. Chem. Lett., 2005, 5, 4456-8.
25. Cui, J.; Li, S. Structure, chemistry and pharmacology of naphthoflavones. Mini. Rev. Med. Chem., 2013, 13, 1357-68.
26. Barros, A. I.; Silva, A. M. Synthesis and structure elucidation of five series of aminoflavones using 1D and 2D NMR spectroscopy. Magn. Reson. Chem.. 2006, 44, 1122-7.
27. Lin, Y. M.; Zhou, Y; Flavin, M. T.; Zhou, L. M.; Nie, W.; Chen, F. C. Chalcones and flavonoids as anti-tuberculosis agents. Bioorg. Med. Chem. 2002, 10, 2795-802.